Where is Metabolus located?

Metabolus is headquartered in San Diego, United States.

How many employees does Metabolus have?

As of Dec 31, 2022, Metabolus has 33 employees, reflecting a 10% year-over-year decline in headcount.

Where does Metabolus rank among its competitors?

Metabolus ranks 14th amongst 15 active competitors, of which 5 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was MARAbio, which secured $19.1M in Sep, 2024.

Who are the top competitors of Metabolus?

Metabolus' top competitors include Linus Biotechnology, MARAbio and Lineagen. Among them, MARAbio secured the most recent funding round in September, 2024.

Metabolus - 2026 Company Profile, Team, Funding & Competitors

Metabolus is a deadpooled company based in San Diego (United States), founded in 2015 by William Alaynick. It operates as a Diagnostics for neurodegenerative and neuropsychiatric disorders. The company has 15 active competitors, including 5 funded and 1 that has exited. Its top competitors include companies like Linus Biotechnology, MARAbio and Lineagen.

Company Details

Metabolus develops diagnostics for neurodegenerative and neuropsychiatric disorders. Its assays are based on biomarkers associated with common CNS disorders who do not have reliable genetic markers. First application is a diagnostic assay for autism spectrum disorders that appears to use metabolomics.

Key Metrics

Founded Year

2015

Location

San Diego, United States

Stage

Deadpooled

Investors

ScholarNexus

Ranked

14^th among 15 active competitors

Employee Count

33 as on Dec 31, 2022

Similar Companies

Linus Biotechnology & 14 more

View Metabolus' full profile

Metabolus is a funded company. Metabolus has 1 institutional investor.

View details of Metabolus's funding rounds and investors

The founders of Metabolus is William Alaynick.

Here are the details of Metabolus' key team members:

William Alaynick: CEO & Founder of Metabolus and founder of 2 other companies, Defined Bioscience and Arima Genomics. They serve on the board of 1 company.

View details of Metabolus's Founder profiles and Board Members

Metabolus' employee count trend

Metabolus has 33 employees as of Dec 22. The total employee count is 11.0% lower than what it was in Dec 21. Here is Metabolus's employee count trend over the years:

Uncover Metabolus' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Metabolus include Linus Biotechnology, MARAbio and Lineagen. Here is the list of Top 10 competitors of Metabolus, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Linus Biotechnology 2020, New York City (United States), Series A	Developer of diagnostic tests for central nervous system and gastrointestinal disorders	$47.6M	GreatPoint Ventures, Bow Capital & 3 others	54/100
2nd	MARAbio 2016, Salt Lake City (United States), Series A	Developer of blood test for detecting maternal autoantibody-related autism	$19.1M	MAK Capital, Moai Capital	50/100
3rd	Lineagen 2002, Salt Lake City (United States), Acquired	Sequencing-based diagnostic test and consultative services for autism	$66.9M	Health Quest Capital, Mesa Verde Venture Partners ... & 10 others	46/100
4th	SynapDx 2010, Southborough (United States), Deadpooled	Developer of blood-based diagnostic tests for the early detection of autism	$32.8M	Google Ventures, North Bridge Venture Partners ... & 7 others	38/100
5th	FBB Biomed 2020, Coralville (United States), Seed	Developer of in-vitro diagnostic test for COVID-19 and neurological diseases	$401K	-	28/100
6th	Leeza 2023, Hyderabad (India), Unfunded	AI-powered screening assessments for the early detection of autism	-	-	27/100
7th	BioROSA Technologies 2018, Boston (United States), Seed	Developer of blood tests for early detection of Autism Spectrum Disorder	$1.03M	IndieBio, OCA Ventures & 2 others	26/100
8th	SensOmics 2007, Toronto (Canada), Seed	Provider of precision medicine for children's health	-	iSeed Ventures, Asset Management Ventures	26/100
9th	Pediatric Bioscience 2006, Sacramento (United States), Deadpooled	Blood biomarker based diagnostics for Autism Spectrum Disorders	$2.44M	Tech Coast Angels, Arizona Tech Investors	24/100
10th	Nevarra Labs 2026, Austria, Unfunded	Developer of blood tests identifying biomarkers for neurological health conditions	-	-	24/100
14th	Metabolus 2015, San Diego (United States), Deadpooled	Diagnostics for neurodegenerative and neuropsychiatric disorders	-	ScholarNexus	18/100